SCHEMBL9870529

SCHEMBL9870529

Cc1cnc2c(C(N)=O)cnn2c1-c1cccc(C(F)(F)F)c1

nearest known ligand 0.67

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.67
ALDH1A1 P00352 2/20 0.50
HPGD P15428 2/20 0.50
MAPK1 P28482 2/20 0.50
HSD17B10 Q99714 2/20 0.50
TLR8 Q9NR97 2/20 0.50
PARP1 P09874 2/20 0.48
MAP2K1 Q02750 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
DYRK1B Q9Y463 1/20 0.45
JAK2 O60674 1/20 0.45
TRPV1 Q8NER1 4/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
BRAF P15056 3/20 0.44
SYK P43405 2/20 0.43
CYP17A1 P05093 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11462373 0.81 CYP17A1 (0.47) KDM4EALDH1A1HPGDHSD17B10DYRK1B
SCHEMBL8435070 0.80 KDM4E (1.00) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL9468727 0.78 KDM4E (0.65) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL14881963 0.76 KDM4E (0.72) KDM4EALDH1A1HPGDMAPK1HSD17B10
SCHEMBL10335729 0.76 RAB9A (0.48) KDM4EALDH1A1HPGDTLR8PARP1
SCHEMBL4713948 0.75 BRAF (0.77) BRAF
SCHEMBL4709669 0.73 KDM4E (0.52) KDM4EALDH1A1HPGDHSD17B10TLR8
SCHEMBL11473815 0.73 CYP17A1 (0.51) KDM4EALDH1A1HPGDHSD17B10DYRK1B
SCHEMBL4655997 0.73 BRAF (0.56) BRAF
SCHEMBL3172240 0.71 KDM4E (0.80) KDM4ETLR8BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5013737-A Hypotensive, anxiolytic, cognitive disorders AMERICAN CYANAMID COMPANY (US) 1991-05-07 US disclosed
US-4916137-A 5-(Substituted-amino)-8-(phenyl or substituted-phenyl)-3H,6H-1,4,5A,8A-tetraazaacenaphthylen-3-ones and treatment of neural behavior disorders AMERICAN CYANAMID COMPANY (US) 1990-04-10 US disclosed